Shouyao Holdings (Beijing) Co., LTD. (SHA:688197)
China · Delayed Price · Currency is CNY 35.75
+0.85 (2.44%)
Nov 5, 2026, 4:00 PM EST
SHA:688197 Market Cap
SHA:688197 has a market cap or net worth of 5.32 billion as of November 5, 2026. It is the 11,552nd most valuable company in the world and the 2,800th biggest in China. Its market cap has decreased by 10.27% in one year.
Market Cap
5.32B
Enterprise Value
4.77B
Revenue
99.90M
Global Rank
Country Rank
#2,800 China
PE Ratio
n/a
ChartMarket Cap Chart
Since March 23, 2022, SHA:688197's market cap has increased from 4.78B to 5.32B, an increase of 11.34%. That is a compound annual growth rate of 2.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 5.32B | 2.91% |
| Dec 31, 2025 | 5.17B | 16.42% |
| Dec 31, 2024 | 4.44B | -45.93% |
| Dec 29, 2023 | 8.21B | 127.31% |
| Dec 30, 2022 | 3.61B | -24.38% |
| Mar 23, 2022 | 4.78B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Hotgen Biotech | 6.08B |
| Zhejiang Ausun Pharmaceutical | 5.92B |
| R&G PharmaStudies | 5.54B |
| PharmaResources (Shanghai) | 5.49B |
| Hangzhou Biotest Biotech | 5.48B |
| Wuhan Keqian Biology Co.,Ltd | 5.40B |
| Youcare Pharmaceutical Group | 4.99B |
| Jiangsu Aidea Pharmaceutical Group | 4.92B |